FEMASYS officer reports 1,411 shares owned

FEMASYS INC reported that officer Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs, filed an initial ownership statement as a reporting person.

Rhea-AI Filing Summary

FEMASYS INC reported that officer Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs, filed an initial ownership statement as a reporting person. He reports direct ownership of 1,411 shares of Common Stock. The filing also references an Exhibit 24 Power of Attorney authorizing representation in SEC matters.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mifek Jeffrey Gerald

Role Chief Clinical-Medical Affairs

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,411 shares (Direct)

Key Figures

Shares owned: 1,411 shares of Common Stock

1 metrics

Shares owned 1,411 shares of Common Stock Directly owned shares reported by officer Jeffrey Gerald Mifek on Form 3

Key Terms

Form 3, Common Stock, Power of Attorney

3 terms

Form 3 regulatory

"filed an initial ownership statement as a reporting person on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Common Stock financial

"He reports direct ownership of 1,411 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Power of Attorney regulatory

"The filing also references an Exhibit 24 Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does FEMASYS INC (FEMY) disclose in this Form 3 for Jeffrey Gerald Mifek?

The Form 3 shows that Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs of FEMASYS INC, reports direct ownership of 1,411 shares of Common Stock as his initial statement of beneficial ownership as an insider.

How many FEMASYS INC (FEMY) shares does Jeffrey Gerald Mifek report owning?

Jeffrey Gerald Mifek reports holding 1,411 shares of FEMASYS INC Common Stock. This figure represents his directly owned shares as stated in his initial Form 3 beneficial ownership report filed as a company officer.

What is Jeffrey Gerald Mifek’s role at FEMASYS INC (FEMY) in this ownership filing?

In this filing, Jeffrey Gerald Mifek is identified as an officer of FEMASYS INC with the title Chief Clinical-Medical Affairs. His position makes him a reporting person required to disclose equity ownership on Form 3.

Does the FEMASYS INC (FEMY) Form 3 show any recent insider buy or sell transactions?

The Form 3 does not report any buy or sell transactions. It functions as an initial ownership statement, listing Jeffery Gerald Mifek’s directly owned 1,411 shares of Common Stock rather than documenting new trading activity.

What additional document is referenced in FEMASYS INC (FEMY) insider Form 3?

The remarks section notes “Exhibit 24 - Power of Attorney”. This indicates a Power of Attorney authorizing a representative to act for the reporting person in connection with SEC filings and related administrative matters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 08:47 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mifek Jeffrey Gerald

(Last) (First) (Middle)

C/O FEMASYS INC.

3950 JOHNS CREEK COURT, SUITE 100

(Street)

SUWANEE GEORGIA 30024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/06/2026

3. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Clinical-Medical Affairs

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,411	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathy Lee-Sepsick, Attorney-in-fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)